MetLife Investment Management, LLC - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$394,723
+4.0%
17,6610.0%0.00%0.0%
Q2 2023$379,535
-7.4%
17,6610.0%0.00%0.0%
Q4 2022$409,735
+25.8%
17,661
-13.2%
0.00%0.0%
Q3 2022$325,799
-9.6%
20,3370.0%0.00%0.0%
Q2 2022$360,372
-22.0%
20,337
-10.4%
0.00%0.0%
Q1 2022$461,907
+76.2%
22,687
+61.7%
0.00%
+50.0%
Q4 2021$262,118
-5.4%
14,0320.0%0.00%
-33.3%
Q3 2021$276,992
-16.7%
14,0320.0%0.00%0.0%
Q1 2021$332,558
+18.3%
14,0320.0%0.00%0.0%
Q4 2020$281,061
-3.8%
14,0320.0%0.00%0.0%
Q3 2020$292,146
+19.0%
14,0320.0%0.00%0.0%
Q2 2020$245,560
+7.2%
14,0320.0%0.00%0.0%
Q1 2020$229,143
-20.7%
14,0320.0%0.00%0.0%
Q4 2019$288,779
+79.3%
14,0320.0%0.00%
+50.0%
Q3 2019$161,087
-12.7%
14,0320.0%0.00%0.0%
Q2 2019$184,521
-13.1%
14,0320.0%0.00%0.0%
Q1 2019$212,444
-11.8%
14,0320.0%0.00%
-33.3%
Q4 2018$240,929
+16.5%
14,0320.0%0.00%
+50.0%
Q3 2018$206,83214,0320.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 2,606,500$51,452,0001.44%
Camber Capital Management LP 2,000,000$39,480,0001.22%
Eventide Asset Management 2,629,593$51,908,0000.68%
GREAT POINT PARTNERS LLC 121,342$2,395,0000.56%
RICE HALL JAMES & ASSOCIATES, LLC 753,038$14,865,0000.55%
Values First Advisors, Inc. 41,773$825,0000.53%
CLARK ESTATES INC/NY 183,800$3,628,0000.52%
EMERALD MUTUAL FUND ADVISERS TRUST 710,398$14,023,0000.48%
EMERALD ADVISERS, LLC 590,256$11,652,0000.42%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 68,812$1,358,0000.42%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders